← Open Payments lookup

ERIN QUINN: Open Payments

NPI 1750749362 · SPOKANE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$936 in 44 payments from 14 companies in 2025. Trend: 2023 $891 · 2024 $1,623 · 2025 $936

Food & beverage: $859Education: $77
CompanyPaymentsAmount
ABBVIE INC.14$267
Janssen Biotech, Inc.3$137
Takeda Pharmaceuticals U.S.A., Inc.6$131
Aimmune Therapeutics, Inc.6$100
PFIZER INC.4$64
Boston Scientific Corporation1$49
GENZYME CORPORATION2$46
Regeneron Healthcare Solutions, Inc.2$34
Biocon Biologics Inc1$21
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$21

Products named: RINVOQ, TREMFYA, ENTYVIO, VOWST, DUPIXENT, XELJANZ, LINZESS, LithoVue.

Industry payments across WA — which companies pay providers there.